Charles River Laboratories International, Inc. CRL

292.84 (1.60) (0.54%) as of 25 Sep
Market cap
$14.1B
P/E
0.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Charles River Laboratories International, Inc. (CRL) Operating margin

Charles River Laboratories International, Inc.'s operating margin over the twelve months to 30 June 2026 was 2.25%, up 1.6 percentage points from fiscal 2025 (0.63%). Over the past ten years it has ranged from 0.63% (fiscal 2025) to 16.7% (fiscal 2021) — the current reading is the lowest in ten years. That is above the Diagnostics & Research industry median of −8.57% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Annual

Period Operating margin Change (points)
FY2025 0.63% (4.98)
FY2024 5.61% (9.34)
FY2023 15.0% (1.42)
FY2022 16.4% (0.29)
FY2021 16.7% 1.86
FY2020 14.8% 1.40
FY2019 13.4% (1.22)
FY2018 14.6% (0.90)
FY2017 15.5% 1.39
FY2016 14.1% (1.01)

Quarterly

Period Operating margin Change (points)
Jun 2026 11.9% (0.10)
Mar 2026 12.0% 40.55
Dec 2025 −28.5% (41.83)
Sep 2025 13.3% 3.62
42 more quarters

Against its own ten years

Low 0.63% High 16.7%
Ten-year median 14.8%
Current reading's percentile 9

Operating margin against peers

Company Operating margin
QGEN QIAGEN N.V. compare 21.2%
MEDP Medpace Holdings, Inc. compare 21.0%
DGX Quest Diagnostics Incorporated compare 14.1%
RVTY Revvity Inc. compare 12.3%
LH Labcorp Holdings Inc. compare 10.4%
ICLR ICON PLC compare 3.57%
CRL Charles River Laboratories International, Inc. 2.25%
TWST Twist Bioscience Corporation compare −33.6%
GH Guardant Health, Inc. compare −39.8%
Diagnostics & Research industry median −8.57%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on CRL